Our findings demonstrate the efficacy of AFSC within the bleomycin injury model and provide data, which suggest a novel mechanistic role for AFSC regulation of CCL2 resulting in the inhibition of parenchymal remodeling and the development of pulmonary fibrosis. Here, CCL2 is linked to pulmonary fibrosis.